In addition, DHA also has been shown to inhibit the development of non-small cell lung cancer metastasis by inhibiting the NF-κB/GLUT1 axis (Jiang et al., 2016) and has been demonstrated to enhance the anti-pancreatic cancer potential of gemcitabine via inhibition of the NF-κB axis (Wang et al., 2010). The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.